Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination

Transplantation

Volumn 68, Issue 11, 1999, Pages 1784-1789

  Witt, Campbell S ^a   Dewing, Christopher ^b   Sayer, David C ^a   Uhrberg, Marcus ^c   Parham, Peter ^c   Christiansen, Frank T ^a,b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; HAPLOTYPE; HLA SYSTEM; HUMAN; KILLER CELL; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TARGET CELL;

EID: 0033573141     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199912150-00024     Document Type: Article

References (23)

1. Wagtmann N, Biassoni R, Cantoni C, et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995; 2: 439.
2. Selvakumar A, Steffens U, Dupont B. NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains. Tissue Antigens 1996; 48; 285.
3. Wagtmann N, Rajagopalan S, Winter CC, Peruzzi M, Long EO. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 1995; 3: 801.
4. Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995; 268: 405.
5. D'Andrea A, Chang C. Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL. Molecular cloning of NKB1: a natural killer cell receptor for HLA-B allotypes. J Immunol 1995; 155: 2306.
6. Valiante NM, Lienert K, Shilling HG, Smits BJ, Parham P. Killer cell receptors: keeping pace with MHC class I evolution. Immunol Rev 1997; 155: 155.
7. Uhrberg M, Valiante NM, Shum BP, et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997; 7: 753.
8. Suto Y, Ishikawa Y, Kasahara M, et al. Gene arrangement of the killer cell inhibitory receptor family of human chromosome 19q13.4 detected by fiber-FISH. Immunogenetics 1998; 48: 235.
9. Yu YYL, Kumar V, Bennett M. Murine natural killer cells and marrow graft rejection. Annu Rev Immunol 1992; 10: 189.
10. Raziuddin A, Longo DL, Mason L, Ortaldo JR, Murphy WJ. Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice. Int Immunol 1996; 8: 1833.
11. Yu YY, George T, Dorfman JR, Roland J, Kumar V, Bennett M. The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts. Immunity 1996; 4: 67.
12. Kung SK, Miller RG. The NK1.1 antigen in NK-mediated F1 antiparent killing in vitro. J Immunol 1995; 154: 1624.
13. Litwin V, Gumperz JE, Parham P, Phillips JH, Lanier LL. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med 1994; 180: 537.
14. Vitale M. Physical and functional independency of p70 and p58 NK cell receptors for HLA-class I: their role in the definition of different groups of alloreactive NK cell clones. Proc Natl Acad Sci USA 1996; 93: 1453.
15. Pende D. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med 1996; 184: 505.
16. Santamaria P, Reinsmoen NL, Lindstrom AL, et al. Frequent HLA class I and DP sequence mismatches in serologically (HLA-A, HLA-B, HLA-DR) and molecularly (HLA-DRB1, HLA-DQA1, HLA-DQB1) HLA-identical unrelated bone marrow transplant pairs. Blood 1994; 83: 280.
17. Sasazuki T, Juji T, Morishima Y, et al. Effect of matching of class I HLA-alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med 1998; 339: 1177.
18. Selvakumar A, Steffens U, Palanisamy N, Chaganti RSK, Dupont B. Genomic organisation and allelic polymorphism of the human killer cell inhibitory receptor gene KIR103. Tissue Antigens 1997; 49: 564.
19. Cavalli-Sforza LL, Bodmer WF, eds. The genetics of human populations. San Francisco: WH Freeman and Company, 1971: 256.
20. Baur MP, Danilovs JA. Population analysis of HLA-A, B, C, DR and other genetic markers. In: Terasaki PI, ed. Histocompatibility testing 1980. Los Angeles: UCLA Tissue Typing Laboratory, 1981: 955.
21. Shilling HG, Lienert-Weidenbach K, Valiante NM, Uhrberg M, Parham P. Evidence for recombination as a mechanism for KIR diversification. Immunogenetics 1998; 48: 413.
22. Dohring C, Scheidegger D, Samaridis J, Cella M, Colonna M. A human killer inhibitory receptor specific for HLA-A. J Immunol 1996; 156: 3098.
23. Valiante NM, Uhrberg M, Shilling HG, et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997; 7: 739.